文献速递贫血与红细胞疾病造血干细胞移植与细胞治疗

单细胞转录组解析再生障碍性贫血造血细胞破坏与T细胞参与

Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia.
PubMed 文献 · Blood · 2021-01-01

该研究对再生障碍性贫血(AA)患者残余造血干/祖细胞(HSPC)与T细胞进行单细胞转录组分析,发现残余HSPC存在谱系特异性基因表达和转录调控网络改变,DNA损伤修复相关转录本可变剪接与多聚腺苷酸化模式异常,并鉴定出T细胞破坏HSPC的配体-受体互作。免疫抑制治疗后造血恢复不完全,伴HSPC-T细胞互作持续异常和转录状态异常。

要点

  • AA残余HSPC谱系特异性转录改变提示定向祖细胞池选择性破坏
  • DNA损伤修复相关转录本剪接与多聚腺苷酸化异常或与进展为MDS相关
  • IST后造血恢复不完全伴HSPC-T细胞互作持续异常

核心结论

  • AA残余HSPC存在谱系特异性转录改变及DNA损伤修复相关转录本剪接与多聚腺苷酸化异常。
  • 鉴定出T细胞破坏HSPC的细胞类型特异性配体-受体互作。
  • IST后造血恢复不完全,伴IST不敏感HSPC-T细胞互作及持续异常转录状态。

研究设计与样本

  • 对AA患者残余HSPC与T细胞进行单细胞转录组分析。
  • 追踪免疫抑制治疗(IST)后患者造血恢复情况。

主要发现

  • 残余HSPC谱系特异性基因表达与转录调控网络改变,提示定向祖细胞池选择性破坏。
  • HSPC中DNA损伤修复相关转录本频繁发生可变剪接改变及多聚腺苷酸化模式偏斜。
  • 鉴定出细胞类型特异性配体-受体互作作为T细胞破坏HSPC的潜在介质。
  • IST后造血恢复不完全,伴HSPC-T细胞间IST不敏感互作及持续异常转录状态。

临床怎么用

  • 单细胞转录组可揭示AA残余HSPC与T细胞互作分子特征。
  • DNA损伤修复相关转录本剪接与多聚腺苷酸化异常提示监测MDS转化风险。
  • IST后需关注HSPC-T细胞互作持续异常及造血恢复不完全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Aplastic anemia (AA) is a T cell-mediated autoimmune disorder of the hematopoietic system manifested by severe depletion of the hematopoietic stem and progenitor cells (HSPCs). Nonetheless, our understanding of the complex relationship between HSPCs and T cells is still obscure, mainly limited by techniques and the sparsity of HSPCs in the context of bone marrow failure. Here we performed single-cell transcriptome analysis of residual HSPCs and T cells to identify the molecular players from patients with AA. We observed that residual HSPCs in AA exhibited lineage-specific alterations in gene expression and transcriptional regulatory networks, indicating a selective disruption of distinct lineage-committed progenitor pools. In particular, HSPCs displayed frequently altered alternative splicing events and skewed patterns of polyadenylation in transcripts related to DNA damage and repair, suggesting a likely role in AA progression to myelodysplastic syndromes. We further identified cell type-specific ligand-receptor interactions as potential mediators for ongoing HSPCs destruction by T cells. By tracking patients after immunosuppressive therapy (IST), we showed that hematopoiesis remission was incomplete accompanied by IST insensitive interactions between HSPCs and T cells as well as sustained abnormal transcription state. These data collectively constitute the transcriptomic landscape of disrupted hematopoiesis in AA at single-cell resolution, providing new insights into the molecular interactions of engaged T cells with residual HSPCs and render novel therapeutic opportunities for AA.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Zhu C, Lian Y, Wang C, et al. Single-cell transcriptomics dissects hematopoietic cell destruction and T-cell engagement in aplastic anemia. Blood. 2021. PMID: 33763704. doi:10.1182/blood.2020008966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。